Status:
COMPLETED
IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Human Immunodeficiency Virus
Eligibility:
MALE
17-24 years
Phase:
NA
Brief Summary
The proposed study will involve adolescent (17-24 years old) men who have sex with men (described as YMSM hereafter) who meet eligibility criteria to participate in each study. Prospective study candi...
Detailed Description
The research activity designated as a clinical trial is our pilot RCT where investigators will then enroll 120 YMSM and randomly assign individuals to one of two experimental groups: (1) information-o...
Eligibility Criteria
Inclusion
- 17-24 years old;
- Individuals who self-identify as male (including transgender men) and report any male sexual partners in the past 6 months;
- Resident of the US based on home address;
- HIV-negative or unknown status based on self-report; and
- Self-reported risk for HIV (based on CDC criteria for PrEP use) defined as reporting any of the following in the past six months:
- Bacterial STI
- Condomless anal sex (CAS) with a casual male sexual partner
- CAS with an HIV-positive or unknown status main partner
- CAS with an HIV-negative main partner who reports CAS with other male partners.
Exclusion
- Current PrEP use;
- Unstable, serious psychiatric symptoms;
- Currently suicidal/homicidal; and
- Evidence of gross cognitive impairment.
Key Trial Info
Start Date :
March 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT04865341
Start Date
March 21 2024
End Date
August 31 2024
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226